ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

33.35
Delayed Data
As of Mar 30
 +1.39 / +4.35%
Today’s Change
15.64
Today|||52-Week Range
46.48
+5.04%
Year-to-Date

Today’s Trading

Previous close31.96
Today’s open32.06
Day’s range-- - --
Volume2,483,289
Average volume (3 months)2,039,551
Market cap$3.2B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-10.85%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book10.33

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+1.17+2.56%
NBIXNeurocrine Bioscienc...+2.75+7.09%
HZNPHorizon Pharma PLC+3.97+18.20%
WXWuxi Pharmatech Caym...+0.88+2.34%
Data as of 03/30/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger M. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account